Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "A10BB" (48)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Glibenclamide (A10BB01) 4 products
WHO-DDD
DrugBank.ca
L
IP
CI
Melix
-
T
30 Tablet(s)
3.09
12.60
10 %
Tablets: Glibenclamidum 5 mg
Lagap SA
B / SL / SG
FB
G
L
IP
CI
Melix
-
T
100 Tablet(s)
8.82
26.00
10 %
Tablets: Glibenclamidum 5 mg
Lagap SA
B / SL / SG
FB
G
IP
CI
Semi-Daonil
30 Tablet(s)
1.52
5.85
k.A.
Tablets: Glibenclamidum 2.5 mg
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
CI
Semi-Daonil
60 Tablet(s)
3.09
7.65
k.A.
Tablets: Glibenclamidum 2.5 mg
Sanofi-Aventis
(Suisse) SA
B
FB
G
Gliclazide (A10BB09) 28 products
WHO-DDD
DrugBank.ca
L
IP
CI
Diamicron MR 60 mg
-
T
30 Tablet(s)
8.30
18.20
10 %
Modified release tablets: Gliclazidum 60 mg
Servier (Suisse) SA
B / SL / SO
FB
G
L
IP
CI
Diamicron MR 60 mg
-
T
90 Tablet(s)
21.17
39.30
10 %
Modified release tablets: Gliclazidum 60 mg
Servier (Suisse) SA
B / SL / SO
FB
G
L
IP
CI
Gliclazid retard Zentiva 60 mg
Tabletten
30 Tablet(s)
7.55
17.45
10 %
Gliclazidum 60 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid retard Zentiva 60 mg
Tabletten
90 Tablet(s)
19.25
37.35
10 %
Gliclazidum 60 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid MR Sandoz 60mg
30
7.84
17.75
10 %
Delayed release tablets: Gliclazidum 60 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid MR Sandoz 60mg
90
19.25
37.35
10 %
Delayed release tablets: Gliclazidum 60 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid retard Zentiva 30 mg
30
3.09
12.60
10 %
Delayed release tablets: Gliclazidum 30 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid retard Zentiva 30 mg
120
10.66
28.10
10 %
Delayed release tablets: Gliclazidum 30 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid-Mepha 30 retard
30
3.92
13.45
10 %
Delayed release tablets: Gliclazidum 30 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid-Mepha 30 retard
120 Tablet(s)
12.83
30.30
10 %
Delayed release tablets: Gliclazidum 30 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid-Mepha 60 retard
30 Tablet(s)
7.84
17.75
10 %
Delayed release tablets: Gliclazidum 60 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid-Mepha 60 retard
90 Tablet(s)
19.25
37.35
10 %
Delayed release tablets: Gliclazidum 60 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid Spirig HC
Retard 60 mg
30 Tablet(s)
7.55
17.45
10 %
Tabletten mit veränderter Wirkstofffreisetzung: Gliclazidum 60 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid Spirig HC
Retard 60 mg
90 Tablet(s)
19.25
37.35
10 %
Tabletten mit veränderter Wirkstofffreisetzung: Gliclazidum 60 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid Spirig HC
Retard 60 mg
120 Tablet(s)
24.76
43.35
10 %
Tabletten mit veränderter Wirkstofffreisetzung: Gliclazidum 60 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Gliclazid-Mepha 30 retard
20 Tablet(s)
2.61
7.10
k.A.
Delayed release tablets: Gliclazidum 30 mg
Mepha Pharma AG
B
FB
G
IP
CI
Gliclazid-Mepha Teva MR 30 mg
30
k.A.
Delayed release tablets: Gliclazidum 30 mg
Mepha Pharma AG
B
FB
G
IP
CI
Gliclazid-Mepha Teva MR 30 mg
120
k.A.
Delayed release tablets: Gliclazidum 30 mg
Mepha Pharma AG
B
FB
G
IP
CI
Gliclazid-Mepha Teva MR 60 mg
30
k.A.
Delayed release tablets: Gliclazidum 60 mg
Mepha Pharma AG
B
FB
G
IP
CI
Gliclazid-Mepha Teva MR 60 mg
90
k.A.
Delayed release tablets: Gliclazidum 60 mg
Mepha Pharma AG
B
FB
G
IP
CI
Diamicron MR 30 mg
-
T
20 Tablet(s)
4.42
9.15
k.A.
Modified release tablets: Gliclazidum 30 mg
Servier (Suisse) SA
B
FB
G
IP
CI
Diamicron MR 30 mg
-
T
60 Tablet(s)
k.A.
Modified release tablets: Gliclazidum 30 mg
Servier (Suisse) SA
B
FB
G
IP
CI
Diamicron MR 30 mg
-
T
120 Tablet(s)
22.78
42.55
k.A.
Modified release tablets: Gliclazidum 30 mg
Servier (Suisse) SA
B
FB
G
IP
CI
Gliclazid Spirig HC
Retard 60 mg
60 Tablet(s)
k.A.
Tabletten mit veränderter Wirkstofffreisetzung: Gliclazidum 60 mg
Spirig HealthCare AG
B
FB
G
Gliclazid MR Servier 30mg
20 Tablet(s)
k.A.
Servier (Suisse) SA
B
FB
G
Gliclazid MR Servier 60mg
30 Tablet(s)
k.A.
Servier (Suisse) SA
B
FB
G
Gliclazid MR Servier 60mg
90 Tablet(s)
k.A.
Servier (Suisse) SA
B
FB
G
Gliclazid MR Servier 30mg
120 Tablet(s)
k.A.
Servier (Suisse) SA
B
FB
G
Glimepiride (A10BB12) 16 products
WHO-DDD
DrugBank.ca
L
IP
CI
Glimeryl-Mepha 1 mg
30 Tablet(s)
1.62
11.00
10 %
Tablets: Glimepiridum 1 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Glimeryl-Mepha 1 mg
120 Tablet(s)
5.62
15.35
10 %
Tablets: Glimepiridum 1 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Glimeryl-Mepha 2 mg
30 Tablet(s)
2.84
12.30
10 %
Tablets: Glimepiridum 2 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Glimeryl-Mepha 2 mg
120 Tablet(s)
9.25
26.45
10 %
Tablets: Glimepiridum 2 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Glimeryl-Mepha 3 mg
30 Tablet(s)
3.93
13.50
10 %
Tablets: Glimepiridum 3 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Glimeryl-Mepha 4 mg
30 Tablet(s)
4.75
14.40
10 %
Tablets: Glimepiridum 4 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Glimeryl-Mepha 4 mg
120 Tablet(s)
16.14
33.95
10 %
Tablets: Glimepiridum 4 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Glimeryl-Mepha 3 mg
120 Tablet(s)
13.51
31.10
10 %
Tablets: Glimepiridum 3 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Glimepirid-Teva 1mg
30 Tablet(s)
1.79
6.15
k.A.
Teva Pharma AG
B
FB
G
IP
CI
Glimepirid-Teva 2mg
30 Tablet(s)
4.41
9.15
k.A.
Teva Pharma AG
B
FB
G
IP
CI
Glimepirid-Teva 3mg
30 Tablet(s)
5.00
13.95
k.A.
Teva Pharma AG
B
FB
G
IP
CI
Glimepirid-Teva 4mg
30 Tablet(s)
5.22
14.20
k.A.
Teva Pharma AG
B
FB
G
IP
CI
Glimepirid-Teva 1mg
120 Tablet(s)
10.06
19.75
k.A.
Teva Pharma AG
B
FB
G
IP
CI
Glimepirid-Teva 2mg
120 Tablet(s)
13.36
27.60
k.A.
Teva Pharma AG
B
FB
G
IP
CI
Glimepirid-Teva 3mg
120 Tablet(s)
16.29
35.10
k.A.
Teva Pharma AG
B
FB
G
IP
CI
Glimepirid-Teva 4mg
120 Tablet(s)
19.18
38.40
k.A.
Teva Pharma AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home